Question Everything. See who's reporting it.

Centre caps cancer drug trade margins at 30% of MRP

Source: Times of India

The story in brief

Karnataka’s health department welcomed the Centre’s decision to cap trade margins at 30% of the MRP for non-scheduled anti-cancer drugs. The move follows an inspection revealing mark-ups of up to 50 times the procurement cost. Officials called it a significant policy change after Karnataka’s investigation.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX